Skip to content

Blood Glucose Homeostasis in Type 2 Diabetes: the Effects of Saccharose

Blood Glucose Homeostasis in Type 2 Diabetes: the Effects of Saccharose

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00821665
Enrollment
39
Registered
2009-01-13
Start date
2007-03-31
Completion date
2008-09-30
Last updated
2009-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycemic Control, Type 2 Diabetes

Keywords

Type 2 diabetes, Glycemic control, (postprandial) Hyperglycemia, Sucrose

Brief summary

Hyperglycemia forms a direct and independent risk factor for the development of cardiovascular co-morbidities in type 2 diabetes. Consumption of sucrose-sweetened soft drinks might further increase the prevalence of hyperglycemic episodes. The objective of the study was to assess glycemic control in type 2 diabetes patients and healthy lean and obese controls under strict dietary standardization but otherwise free living conditions, with and without the consumption of soft drinks.

Interventions

DIETARY_SUPPLEMENTSucrose consumption

Sucrose

DIETARY_SUPPLEMENTwater consumption

water

Sponsors

Suikerstichting Nederland (Baarn)
CollaboratorUNKNOWN
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
40 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Lean NGT Group * Normoglycemic (according to 2006 ADA guidelines) * BMI \< 27 kg/m2 Obese NGT Group * Normoglycemic * BMI 30- 35 kg/m2 Obese type 2 diabetes Group * BMI 30- 35 kg/m2 * Oral blood glucose lowering medication

Exclusion criteria

* Exogenous insulin use * Cardiac disease (any cardiac event in the last 5 years) * HbA1c \>10% * Microalbuminuria: albumin:creatinine ratio \>2,5

Design outcomes

Primary

MeasureTime frame
Hyperglycemia24h

Secondary

MeasureTime frame
HyperglycemiaPostprandially

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026